1. Home
  2. SYBX vs AIRI Comparison

SYBX vs AIRI Comparison

Compare SYBX & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • AIRI
  • Stock Information
  • Founded
  • SYBX N/A
  • AIRI 1979
  • Country
  • SYBX United States
  • AIRI United States
  • Employees
  • SYBX N/A
  • AIRI N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • SYBX Health Care
  • AIRI Industrials
  • Exchange
  • SYBX Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • SYBX 13.9M
  • AIRI 13.4M
  • IPO Year
  • SYBX N/A
  • AIRI N/A
  • Fundamental
  • Price
  • SYBX $1.48
  • AIRI $3.40
  • Analyst Decision
  • SYBX
  • AIRI
  • Analyst Count
  • SYBX 0
  • AIRI 0
  • Target Price
  • SYBX N/A
  • AIRI N/A
  • AVG Volume (30 Days)
  • SYBX 96.1K
  • AIRI 1.6M
  • Earning Date
  • SYBX 08-15-2025
  • AIRI 08-13-2025
  • Dividend Yield
  • SYBX N/A
  • AIRI N/A
  • EPS Growth
  • SYBX N/A
  • AIRI N/A
  • EPS
  • SYBX 0.21
  • AIRI N/A
  • Revenue
  • SYBX N/A
  • AIRI $53,182,000.00
  • Revenue This Year
  • SYBX N/A
  • AIRI N/A
  • Revenue Next Year
  • SYBX N/A
  • AIRI $4.99
  • P/E Ratio
  • SYBX $7.06
  • AIRI N/A
  • Revenue Growth
  • SYBX N/A
  • AIRI 0.29
  • 52 Week Low
  • SYBX $0.90
  • AIRI $3.00
  • 52 Week High
  • SYBX $1.96
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.72
  • AIRI 47.12
  • Support Level
  • SYBX $1.53
  • AIRI $3.37
  • Resistance Level
  • SYBX $1.96
  • AIRI $3.51
  • Average True Range (ATR)
  • SYBX 0.19
  • AIRI 0.11
  • MACD
  • SYBX -0.01
  • AIRI -0.01
  • Stochastic Oscillator
  • SYBX 36.84
  • AIRI 32.14

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: